MoneyWorks4Me

The company witnessed a 11.58% growth in the revenue at Rs. 1337.66 millions for the quarter ended December 2022 as compared to Rs. 1198.80 millions during the year-ago period.Net profit stood at Rs. 216.14  millions  compared to Rs. 176.01 millions in the corresponding previous quarter,high by 22.80%.Operating profit surged to 331.10 millions from the corresponding previous quarter of 260.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1337.66 1198.80 11.58 3978.49 3695.37 7.66 4720.79 4229.08 11.63
Other Income 63.58 26.35 141.29 185.38 81.07 128.67 99.98 57.43 74.09
PBIDT 331.10 260.85 26.93 911.09 861.40 5.77 1054.68 927.83 13.67
Interest 3.31 3.05 8.52 8.81 8.84 -0.34 14.51 15.52 -6.51
PBDT 327.79 257.80 27.15 902.28 852.56 5.83 1040.17 912.31 14.01
Depreciation 22.62 21.81 3.71 67.53 60.90 10.89 80.88 75.60 6.98
PBT 305.17 235.99 29.31 834.75 791.66 5.44 959.29 836.71 14.65
TAX 89.03 59.98 48.43 231.37 208.36 11.04 265.74 214.21 24.06
Deferred Tax 4.36 2.46 77.24 5.75 1.56 268.59 7.20 2.47 191.50
PAT 216.14 176.01 22.80 603.38 583.30 3.44 693.55 622.50 11.41
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 24.75 21.76 13.75 22.90 23.31 -1.76 22.34 21.94 1.83
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..